Medtronic plc Stock
€65.54
Your prediction
Medtronic plc Stock
Pros and Cons of Medtronic plc in the next few years
Pros
Cons
Performance of Medtronic plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medtronic plc | 0.520% | 1.424% | -11.216% | -14.883% | -20.112% | -20.209% | -36.461% |
| Dexcom Inc. | 6.830% | 2.713% | 1.533% | -30.827% | -7.537% | -51.809% | -22.797% |
| Teleflex Inc. | -0.810% | -1.771% | 3.936% | -0.982% | 8.725% | -50.929% | -65.559% |
| Baxter International | -1.550% | -2.520% | -0.168% | -46.344% | -8.575% | -62.195% | -78.426% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Upon first glance at Medtronic's financials, the company appears to be a strong player in the Healthcare Equipment & Supplies sector. Over the years, Medtronic has demonstrated relatively stable financial performance, which is a desirable attribute for a healthcare company. However, more in-depth analysis is needed to better understand the pros and cons of its financial situation.
Revenue Growth: Medtronic's total revenue has experienced consistent growth over the last three years as seen in the yearly income statements. In 2020, the company recorded total revenue of $28.913 billion which increased to $30.117 billion in 2021, and further to $31.686 billion in 2022.
Increasing Gross Profit: Medtronic has seen a rise in its gross profit, from $19.489 billion in 2020 to $19.634 billion in 2021, and eventually $21.541 billion in 2022. This implies that the company is becoming more efficient in its manufacturing and supply chain activities, which is a good sign for potential investors.
Comments
News
3 Stocks With Monster Potential to Hold Through the Next Decade of Uncertainty
The world is uncertain today, with geopolitical conflicts unfolding across multiple regions. The market is uncertain, with stocks at record highs despite consumer concerns about high costs and the
Why Savvy Investors Are Loading Up on This Beaten-Down Stock
Shares of Medtronic (NYSE: MDT) are down 40% from their 2021 high. The dividend yield is a historically high 3.6%. Although this medical device maker is deeply unloved, now could be a good time for
3 Healthcare Stocks Every Retiree Should Consider
One of the biggest reasons to include some exposure to healthcare in your portfolio is simple logic: Healthcare isn't optional. If someone is ill, they need to address the problem, because the